San Diego, CA, United States of America

Michael Malakhov

This inventor holds 0 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent.


 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...
Loading Chart...

Title: Michael Malakhov: Innovator in Pathogen Treatment

Introduction

Michael Malakhov is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of pathogen treatment through his innovative research and inventions. His work focuses on developing new compositions and methods to prevent and treat infections caused by various pathogens.

Latest Patents

Michael Malakhov's latest patent, titled "Sialidase Catalytic Domain Proteins," presents groundbreaking compositions and methods for preventing and treating pathogen infections. This invention provides compounds with an anchoring domain that attaches to the surface of target cells, along with a therapeutic domain that acts extracellularly to prevent infections by pathogens, such as viruses. The patent also includes therapeutic compositions with sialidase activity, which can be utilized to treat or prevent infections and reduce allergic and inflammatory responses. Additionally, the invention offers methods for enhancing the transduction of target cells by recombinant viruses, which can be applied in gene therapy.

Career Highlights

Throughout his career, Michael Malakhov has worked with notable companies, including Ansun Biopharma, Inc. and Fang Fang. His experience in these organizations has contributed to his expertise in the field of biotechnology and pathogen treatment.

Collaborations

Michael has collaborated with Fang Fang, further enhancing his research and development efforts in the area of pathogen treatment.

Conclusion

Michael Malakhov is a dedicated inventor whose work in pathogen treatment has the potential to significantly impact public health. His innovative approaches and collaborations continue to pave the way for advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…